USP21 Antibodies

Santa Cruz Biotechnology provides a broad selection of USP21 monoclonal antibodies for advanced research in cellular biology. USP21 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). USP21, or Ubiquitin Specific Peptidase 21, regulates protein degradation and cellular signaling pathways by removing ubiquitin moieties from target proteins. This function maintains cellular homeostasis and influences processes such as cell cycle progression and apoptosis. USP21's involvement in various diseases, including cancer, makes it a significant target for therapeutic intervention and biomarker discovery. Understanding USP21's molecular mechanisms can provide insights into disease development and potential treatment strategies. Investigating USP21's role in cellular pathways may reveal new therapeutic approaches for various pathological conditions. Research focusing on USP21's function in different tissue types can enhance our understanding of its biological significance. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic strategies.